5 studies found for:    Naurex | Phase 2
Show Display Options
Rank Status Study
1 Not yet recruiting NRX-1074 in Early Course Schizophrenia
Condition: Schizophrenia
Interventions: Drug: NRX-1074;   Drug: Placebo
2 Active, not recruiting Open Label Extension for GLYX13-C-202, NCT01684163
Condition: Major Depressive Disorder
Intervention: Drug: GLYX-13 10 mg/kg
3 Completed Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: NRX-1074 1 mg;   Drug: Placebo;   Drug: NRX-1074 5 mg;   Drug: NRX-1074 10 mg
4 Completed Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants
Condition: Major Depressive Disorder
Interventions: Drug: GLYX-13 5 mg/kg;   Drug: GLYX-13 10 mg/kg;   Drug: Placebo
5 Completed Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression
Condition: Major Depressive Disorder
Intervention: Drug: GLYX-13

Indicates status has not been verified in more than two years